PREDSTAVITEV / INTRODUCTION | ČLANI / MEMBERS | PROJEKTI / PROJECTS | PUBLIKACIJE / PUBLICATIONS | DOGODKI / EVENTS | INFORMACIJE ZA ŠTUDENTE

ARHIV DOGODKOV IN UDELEŽB

PRETEKLI DOGODKI / PAST EVENTS

2018

Dan odprtih vrat Laboratorija za farmakogenetiko / Pharmacogenetics laboratory Open day event

01. 12. 2018

9 - 13h, Srednja predavalnica Medicinske fakultete, Korytkova 2, Ljubljana

Ob tednu Univerze v Ljubljani želimo raziskovalci Laboratorija za farmakogenetiko skupaj s kliničnimi sodelavci s področjem farmakogenetike ter z našim delom in dosežki seznaniti čim širši krog ljudi: zdravnike in druge zdravstvene delavce in sodelavce, farmacevte, raziskovalce, študente, predvsem pa bolnike in širšo javnost.

Letošnji Dan odprtih vrat je posvečen predstavitvi personalizirane medicine in preemptivnega farmakogenomskega testiranja pri nas, predstavitvi evropskega projekta Obzorja 2020 Ubiquitous Pharmacogenomics (U-PGx) in predstavitvam izkušenj sodelavcev na tem projektu. V drugem delu pa bodo predstavljene raziskovalne teme in naši rezultati na področju farmakogenetike nevrodegenerativnih bolezni, presnovnih motenj in raka.

Vstop je prost, predhodna prijava ni potrebna. Vljudno vabljeni.

Program / Programme

1st HBM4EU Training School

22. 06. 2018

A05 Biomarkers of effect

Seminar, Inštitut za biokemijo, Medicinska Fakulteta, Univerza v Ljubljani, Vrazov trg 2, Ljubljana

Spletna stran / website

Program / Programme

2017

Dan odprtih vrat Laboratorija za farmakogenetiko / Pharmacogenetics laboratory Open day event

02. 12. 2017

9 - 13h, Srednja predavalnica Medicinske fakultete, Korytkova 2, Ljubljana

Letošnji Dan odprtih vrat Laboratorija za farmakogenetiko je posvečen predstavitvi evropskega projekta U-PGx, predstavitvam izkušenj sodelavcev na tem projektu in raziskovalnim temam s področja farmakogenomike nevrodegenerativnih bolezni in epilepsije.

Vstop je prost, predhodna prijava ni potrebna. Vljudno vabljeni.

Program Dneva odprtih vrat 2017 / Programme

Frankfurt po Frankfurtu

06. 11. - 11. 11. 2017

Spletna stran / website

Program

Delavnica: Študija PREPARE v Sloveniji: PREemptive Pharmacogenomic testing for Preventing Adverse drug Reactions

17. 05. 2017

Univerzitetna psihiatrična klinika Ljubljana

Delavnica: PREPARE Study Refresher Site Initiation Visit

12. 04. 2017

Seminar, Inštitut za biokemijo, Medicinska Fakulteta, Univerza v Ljubljani, Vrazov trg 2, Ljubljana

Delavnica: Študija PREPARE / PREPARE Study

03. 04. 2017

Zdravstveni dom Ljubljana

2016

Delavnica: Študija PREPARE v Sloveniji: PREemptive Pharmacogenomic testing for Preventing Adverse drug Reactions

14. 12. 2016

Splošna bolnišnica Trbovlje

Dan odprtih vrat Laboratorija za farmakogenetiko / Pharmacogenetics laboratory Open day event

10. 12. 2016

9 - 13h, Srednja predavalnica Medicinske fakultete, Korytkova 2, Ljubljana

Letošnji Dan odprtih vrat Laboratorija za farmakogenetiko je posvečen predstavitvi evropskega projekta U-PGx, predstavitvam sodelavcev na tem projektu in raziskovalnim temam s področja farmakogenomike v onkologiji.

Vstop je prost, predhodna prijava ni potrebna. Vljudno vabljeni.

Program Dneva odprtih vrat 2016 / Programme

Uvodna delavnica za zdravstvene delavce, ki sodelujejo v klinični raziskavi PREPARE / PREPARE Study Initiation Visit

08. 12. 2016

9 - 14h, Seminar, Inštitut za biokemijo, Medicinska Fakulteta, Univerza v Ljubljani, Vrazov trg 2, Ljubljana

Program / Programme

Personalizirana medicina: od farmakogenomskih analiz do bolniku prilagojenega zdravljenja / Personalized medicine: from pharmacogenomic analyses to personalized treatment

29. 11. 2016

12 - 15h, Zdravstveni dom Ljubljana, enota Šiška, Derčeva ulica 5, predavalnica, 4. nadstropje

Delavnica za zdravnike družinske medicine / Workshop for general practitioners

Program / Programme

Workshop for Human NGS Data Analysis and Interpretation (organized by Qiagen)

12. 09. 2016 – 13. 09. 2016

Seminar 1, Inštitut za biokemijo, Medicinska Fakulteta, Univerza v Ljubljani, Vrazov trg 2, Ljubljana

Spletna stran / website

SUMMER SCHOOL GENOMIC MEDICINE – Bridging research and the clinic

03. 05. 2016 – 07. 05. 2016

Hotel Histrion, Portorož

Spletna stran / website

2015

Dan odprtih vrat Laboratorija za farmakogenetiko / Pharmacogenetics laboratory Open day event

5. 12. 2015

9 - 13h Srednja predavalnica Medicinske fakultete, Korytkova 2, Ljubljana.

Program Dneva odprtih vrat 2015 / Programme

Mala šola farmakogenetike / Pharmacogenetics - basic training

14. 11. 2015

Program Male šole farmakogenetike / Programme

Farmakogenomika - iz raziskav v klinično prakso / Pharmacogenomics - from research to clinical practice

Delavnica za visokošolske učitelje / Workshop for university lecturers, 8. 6. 2015 – 10. 6. 2015

Program delavnice / Programme

UDELEŽBA NA DOGODKIH / PARTICIPATION

2018

• 14^th International Conference of the International Mesothelioma Interest Group: 02. 05. – 05. 05. 2018, Ottawa, Canada (Website)

DOLŽAN, Vita, GORIČAR, Katja, KOVAČ, Viljem. Genetic polymorphisms of PD-L1 may influence response to platinum-based chemotherapy in malignant mesothelioma (poster).

• 44. strokovno srečanje timov: 01. 06. – 02. 06. 2018, Ljubljana, Slovenia

DOLŽAN, Vita, BLAGUS, Tanja, GORIČAR, Katja, REDENŠEK, Sara, ŽUGEC, Maja, MLINŠEK, Gregor, VIVOD PEČNIK, Živka, MAZEJ POREDOŠ, Barbara, POPLAS-SUSIČ, Tonka, ŠKRINJAR, Andrej, ZIDANŠEK, Anja, RAJTER, Branka, ČAUŠ, Azra, JUTERŠEK, Milojka, DERNOVŠEK, Mojca Zvezdana, TERZIČ, Tea, JERAS, Katja, SAJE, Marko, VRBNJAK, Marko, KORES-PLESNIČAR, Blanka, PLEMENITAŠ, Anja. Kaj lahko genetika doprinese k predpisovanju zdravil (invited lecture).

• ESHG 2018 Meeting: 16. 06. – 19. 06. 2018, Milan, Italy (Website)

REDENŠEK, Sara, TROŠT, Maja, DOLŽAN, Vita. The effect of inflammation-related genetic polymorphisms on the occurrence of non-motor adverse events of dopaminergic treatment in Parkinson's disease (poster).

BLAGUS, Tanja, SOLDAT, Savica, GORIČAR, Matej, GORIČAR, Katja, REDENŠEK, Sara, DOLŽAN, Vita, KONTA, Lidija. Genotyping approach supporting pre-emptive pharmacogenomics testing : the Slovenian experience within the UPGx project (poster).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. Immune checkpoints PD-1 and PD-L1 polymorphisms and outcome of cisplatin-based chemotherapy in malignant mesothelioma (poster).

DOLŽAN, Vita, BLAGUS, Tanja, REDENŠEK, Sara, GORIČAR, Katja, SOLDAT, Savica, MLINŠEK, Gregor, VIVOD PEČNIK, Živka, MAZEJ POREDOŠ, Barbara, ŠKRINJAR, Andrej, ZIDANŠEK, Anja, RAJTER, Branka, ČAUŠ, Azra, JERAS, K., SAJE, Marko, KLEN, Jasna, JUTERŠEK, M., KOLŠEK-ŠUŠTERŠIČ, Maja, POPLAS-SUSIČ, Tonka, PRICA, Mojca, STEGNE IGNJATOVIĆ, Tea, JAKOPIČ ŽLAHTIČ, R., TERZIČ, Tea, VRBNJAK, Marko, BOKALIČ, Melita, BUKOVEC, Lenart, RUS-MAKOVEC, Maja, KOKOT, Simona, DOBLEKAR, S., VERBOTEN KOPRIVA, Renata, EJUPI, Betim, KORES-PLESNIČAR, Blanka. PREemptive pharmacogenomic testing for preventing adverse drug reactions (PREPARE) study : the Slovenian experience within the UPGx project (poster).

• Taste of genomics: 20. 06. – 21. 06. 2018, Ljubljana, Slovenia (Website)

DOLŽAN, Vita, BLAGUS, Tanja, ŽUGEC, Maja, GORIČAR, Katja, REDENŠEK, Sara, MLINŠEK, Gregor, KLEN, Jasna, VIVOD PEČNIK, Živka, MAZEJ POREDOŠ, Barbara, POPLAS-SUSIČ, Tonka, ŠKRINJAR, Andrej, ZIDANŠEK, Anja, RAJTER, Branka, ČAUŠ, Azra, JUTERŠEK, Milojka, DERNOVŠEK, Mojca Zvezdana, TERZIČ, Tea, JERAS, Katja, SAJE, Marko, VRBNJAK, Marko, KORES-PLESNIČAR, Blanka, PLEMENITAŠ, Anja. Ubiquitous Pharmacogenomics : from genetic variability to treatment recommendations (invited lecture).

• Genetika 2018: 19. 09. – 21. 09. 2018, Radenci, Slovenia (Website)

GORIČAR, Katja, FRANKO, Alenka, DODIČ-FIKFAK, Metoda, KOVAČ, Viljem, DOLŽAN, Vita. Association of MSLN polymorphism with serum mesothelin levels and survival in malignant mesothelioma (short presentation).

BLAGUS, Tanja, HRIBERNIK, Nežka, SNOJ ŠARVARI, Nataša, BOC, Marko, DOLŽAN, Vita. Molecular mechanisms of fluoropyrimidine toxicity beyond DPYD : case report (poster).

REDENŠEK, Sara, TROŠT, Maja, DOLŽAN, Vita. Genetic variability in oxidative stress pathways influences the occurrence of adverse events of dopaminergic treatment in Parkinson's disease (short presentation).

2017

• The 3rd SysBioMed hands-on tutorial: Systems Medicine Approaches in Personalized Medicine: 29. 03. - 01. 04. 2017, Ljubljana, Slovenia (Website)

DOLŽAN, Vita. Translation of pharmacogenomics research into clinical practice within the PREPARE study (invited lecture).

• Seminar for Division of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOLŽAN, Vita. Farmakogenomska variabilnost v onkologiji in imunoterapiji (invited lecture).

• 8^th Conference on Experimental and Translational Oncology: 19. 04. – 23. 04. 2017, Portorož, Slovenia (Website)

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. Genetic variability of PD-L1 and response to chemotherapy in malignant mesothelioma (short presentation).

DOLŽAN, Vita. Co-chair, section Biomarkers, new drugs and therapeutic targets II.

• BIT's 7^th Annual World Congress of Molecular & Cell Biology： 25. 04. - 27. 04. 2017, Xian, China

JENKO, Barbara, TOMSIC, Matija, PRAPROTNIK, Sonja, DOLŽAN, Vita. Clinical-pharmacogenetic models for personalized rheumatoid arthritis treatment (invited lecture).

• 2^nd UPGx Personalized Medicine Day: 12. 05. 2017, Vienna, Austria

DOLŽAN, Vita, INNOCENTI, Federico, PATRINOS, George P., INGELMAN-SUNDBERG, Magnus, SWEN, Jesse. Round table discussion: Introducing personalized medicine into clinical practice: hopes and realities (invited speaker).

• European Human Genetics Conference, 50^th Anniversary Meeting: 27. 05. - 30. 05. 2017, Copenhagen, Denmark (Website)

DOLŽAN, Vita, NEWMAN, William. Workshop: Pharmacogenomics (workshop organizers).

• Systems Medicine Conference in Slovenia, National Awareness Event & 12^th CFGBC Symposium and “Systems Medicine” Workshop: 08. 06. - 09. 06. 2017, Ljubljana, Slovenia (Website)

DOLŽAN, Vita, GORIČAR, Katja, REDENŠEK, Sara, BLAGUS, Tanja, for Ubiquitous Pharmacogenomics Consortium. Implementing enabling tools for preemptive pharmacogenomics testing within the Ubiquitous Pharmacogenomics Project: The Slovenian Experience (poster).

JENSTERLE, Mojca, PIRŠ, Boštjan, GORIČAR, Katja, DOLŽAN, Vita, JANEŽ, Andrej. Genetic variation in GLP1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study (poster).

REDENŠEK, Sara, TROŠT, Maja, DOLŽAN, Vita. Genetic variability in pathways defective in Parkinson's disease: possible applications (poster).

• 14^th European ISSX meeting: 26. 06. – 29. 06. 2017, Cologne, Germany

PLEMENITAŠ, Anja, KORES-PLESNIČAR, Blanka, DOLŽAN, Vita. The influence of NLRP3 inflammasome polymorphisms on alcohol dependence (poster).

REDENŠEK, Sara, GORIČAR, Katja, TROŠT, Maja, DOLŽAN, Vita. DRD2 and DRD3 polymorphisms do not affect susceptibility to Parkinson's disease (poster).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. The influence of PD-1 and PD-L1 polymorphisms on cisplatin-related toxicity in malignant mesothelioma (poster).

• 12^th Meeting of the Slovenian Biochemical Society: 20. 09. – 23. 09. 2017, Bled, Slovenia (Website)

BLAGUS, Tanja, GORIČAR, Katja, SOLDAT, Savica, REDENŠEK, Sara, KONTA, Lidija, DOLŽAN, Vita. Implementing genotyping for preemptive pharmacogenomics testing within the U-PGx project : the Slovenian experience (poster).

DOLŽAN, Vita, BLAGUS, Tanja, REDENŠEK, Sara, GORIČAR, Katja, MLINŠEK, Gregor, POPLAS-SUSIČ, Tonka, MAZEJ POREDOŠ, Barbara, VIVOD PEČNIK, Živka, ZIDANŠEK, Anja, KORES-PLESNIČAR, Blanka, VIDIČ HUDOBIVNIK, Polona, KLEN, Jasna. PREemptive Pharmacogenomic testing for Preventing Adverse drug REactions (PREPARE) study : the Slovenian experience (poster).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. Immune checkpoints PD-1 and PD-L1 polymorphisms and chemotherapy outcome in malignant mesothelioma (poster).

REDENŠEK, Sara, GORIČAR, Katja, TROŠT, Maja, DOLŽAN, Vita. Genetic variability in DRD2 and DRD3 does not contribute to Parkinson's disease susceptibility (poster).

• 3. slovenski nevrološki kongres: 10. 11. – 11. 11. 2017, Zreče, Slovenia

REDENŠEK, Sara, TROŠT, Maja, DOLŽAN, Vita. Vpliv genetskih dejavnikov na izid dopaminergičnega zdravljenja Parkinsonove bolezni (short presentation).

2016

• 4. slovensko srečanje o klinični farmakologiji: Varna uporaba zdravil: 22. 01. 2016, Ljubljana, Slovenia (Website)

DOLŽAN, Vita. Uporaba farmakogenetskih testiranj v klinični praksi: mit ali realnost (invited lecture).

• EUPancreas WG2 TRAINING SCHOOL on Interactions in Complex Disease Analysis: 27. 04. – 29. 04. 2016, Antwerp, Belgium (Website)
• Summer school Genomic medicine – Bridging research and the clinic: 03. 05. – 07. 05. 2016, Portorož, Slovenia (Website)

KLEN, Jasna, DOLŽAN, Vita. Pharmacogenetics of type 2 diabetes treatment (invited lecture).

DOLŽAN, Vita. Preemptive testing in pharmacogenomics (invited lecture).

FRANKO, Alenka, DODIČ-FIKFAK, Metoda, DOLŽAN, Vita. Gene environment interactions: the case of asbestosis (invited lecture).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. Clinical-pharmacogenetic model predicting treatment outcome in malignant mesothelioma (short presentation).

ESIH, Katarina, DOLŽAN, Vita. Genetic markers in Alzheimer's disease (poster).

ESIH, Katarina, GORIČAR, Katja, DOLŽAN, Vita, RENER-PRIMEC, Zvonka. Antioxidant enzyme polymorphisms and sequelae neonatal hypoxic-ischaemic brain injury (poster).

JENKO, Barbara, TOMŠIČ, Matija, JEKIĆ, Biljana, MILIĆ, Vera, PRAPROTNIK, Sonja, DOLŽAN, Vita. Clinical pharmacogenetic model or response to methotrexate monotherapy in Slovenian and Serbian rheumatoid arthritis patients: differences in patient's management preclude generalization of the models (poster).

REDENŠEK, Sara, DOLŽAN, Vita. Genetic determinants of Parkinson's disease: can they help to stratify the patients based on the underlying molecular defect? (poster).

REDENŠEK, Sara, TROŠT, Maja, PIRTOŠEK, Zvezdan, DOLŽAN, Vita. Pharmacogenetics of Parkinson's disease: planning of a clinical-pharmacogenetic model for personalized treatment of Parkinson's disease (poster).

FERDIN, Jana, GORIČAR, Katja, DOLŽAN, Vita, PLEMENITAŠ, Ana, DEEKS, Steven G, PETERLIN, Matija Boris, LENASSI, Metka. Plasma of HIV infected patients with undetected viral load contains exosomes with viral protein Nef (poster).

ŠENK, Barbara, GORIČAR, Katja, KRAVOS, Nika Aleksandra, JANEŽ, Andrej, JENSTERLE SEVER, Mojca, DOLŽAN, Vita. SLC6A4 5HTTLPR polymorphism affects insulin secretion in poatients with polycystic ovary syndrome (poster).

• Management Committee and Working Group Meeting, COST Action: CA 15129, DiMoPEx: 16. 06. – 17. 06. 2016, Hamburg, Germany

FRANKO, Alenka, KOVAČ, Viljem, ARNERIĆ, Niko, DODIČ-FIKFAK, Metoda, DOLŽAN, Vita. Soluble mesothelin-related peptides and fibulin-3 as biomarkers in malignant mesothelioma (poster).

FRANKO, Alenka, ARNERIĆ, Niko, DODIČ-FIKFAK, Metoda, DOLŽAN, Vita. Gene environment interactions: the case of asbestosis (poster).

FRANKO, Alenka, KOVAČ, Viljem, ARNERIĆ, Niko, DODIČ-FIKFAK, Metoda, DOLŽAN, Vita. Asbestos related diseases in Slovenia: the search for molecular biomarkers of risk for developing, progress and treatment response needs to go hand-in-hand with education and raising public awareness (poster).

• Training and Education for Advanced Clinicians and HCPs in Personalised Medicine: 03. 07. – 07. 07. 2016, Cascais, Portugal (Website)
• Introduction to the statistical analysis of genome-wide association studies: 04. 07. – 08. 07. 2016, London, UK (Website)
• ELIXIR-SI launch & 11TH CFGBC Symposium "Data for Life": 21. 09. 2016, Ljubljana, Slovenia (Website)

DOLŽAN, Vita, EU-PGx project and EUPancreas COST action – the steps toward the personalized medicine (invited short presentation).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita. Facilitating treatment selection in malignant mesothelioma using clinical-pharmacogenetic models (poster).

REDENŠEK, Sara, TROŠT, Maja, DOLŽAN, Vita. Genetic and clinical determinants of response to treatment in Parkinson's disease: can they help to personalize the treatment? (poster).

• 2016 Golden Helix Summer School "Cancer Genomics and Individualized Therapy": 22. 09. - 26. 09. 2016, Syros, Greece (Website)

KRHIN, Blaž, GORIČAR, Katja, GAZIĆ Barbara, NOVAKOVIČ Srdjan, DOLŽAN, Vita, BEŠIĆ Nikola, Genetic markers of Huerthle Cell neoplasms (short presentation).

GORIČAR, Katja, KOVAČ, Viljem, DOLŽAN, Vita, Clinical-pharmacogenetic model predicting treatment outcome in malignant mesothelioma (lecture).

DOLŽAN, Vita, Personal views on career development (Career development session, short presentation).

• 2^nd BALcanOSH International Conference for Regional Collaboration: 10. 11. - 11. 11. 2016, Bled, Slovenia

DOLŽAN, Vita, DODIČ-FIKFAK, Metoda, FRANKO, Alenka. Vloga genetskih in okoljskih dejavnikov pri boleznih, povezanih z izpostavljenostjo azbestu (invited lecture).

• 12. Dnevi internistične onkologije: DIO 2016: 18. 11. - 19. 11. 2016, Ljubljana, Slovenia

DOLŽAN, Vita. Farmakogenetika v onkologiji - vloga genskih polimorfizmov (invited lecture).